vs
Borealis Foods Inc.（BRLS）与Protalix BioTherapeutics, Inc.（PLX）财务数据对比。点击上方公司名可切换其他公司
Protalix BioTherapeutics, Inc.的季度营收约是Borealis Foods Inc.的1.3倍（$9.1M vs $7.1M），Borealis Foods Inc.净利率更高（-53.2% vs -60.3%，领先7.1%），Borealis Foods Inc.同比增速更快（-12.0% vs -49.9%），过去两年Borealis Foods Inc.的营收复合增速更高（-2.4% vs -6.7%）
Borealis Foods Inc是一家食品科技企业，专注于研发生产高品质植物基蛋白产品，包括植物肉替代品，主要服务北美和欧洲的零售及餐饮客户，致力于提供价格亲民、营养健康的可持续食品。
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
BRLS vs PLX — 直观对比
营收规模更大
PLX
是对方的1.3倍
$7.1M
营收增速更快
BRLS
高出37.9%
-49.9%
净利率更高
BRLS
高出7.1%
-60.3%
两年增速更快
BRLS
近两年复合增速
-6.7%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $7.1M | $9.1M |
| 净利润 | $-3.8M | $-5.5M |
| 毛利率 | 14.6% | 49.4% |
| 营业利润率 | -27.1% | -51.1% |
| 净利率 | -53.2% | -60.3% |
| 营收同比 | -12.0% | -49.9% |
| 净利润同比 | 21.8% | -184.8% |
| 每股收益（稀释后） | $-0.18 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BRLSPLX
| Q4 25 | — | $9.1M | ||
| Q3 25 | $7.1M | $17.9M | ||
| Q2 25 | $7.2M | $15.7M | ||
| Q1 25 | $6.8M | $10.1M | ||
| Q4 24 | $6.8M | $18.2M | ||
| Q3 24 | $8.1M | $18.0M | ||
| Q2 24 | $5.5M | $13.5M | ||
| Q1 24 | $7.9M | — |
净利润BRLSPLX
| Q4 25 | — | $-5.5M | ||
| Q3 25 | $-3.8M | $2.4M | ||
| Q2 25 | $-4.6M | $164.0K | ||
| Q1 25 | $-4.2M | $-3.6M | ||
| Q4 24 | $-5.8M | $6.5M | ||
| Q3 24 | $-4.8M | $3.2M | ||
| Q2 24 | $-6.3M | $-2.2M | ||
| Q1 24 | $-8.4M | — |
毛利率BRLSPLX
| Q4 25 | — | 49.4% | ||
| Q3 25 | 14.6% | 53.4% | ||
| Q2 25 | 7.2% | 62.5% | ||
| Q1 25 | 13.1% | 19.1% | ||
| Q4 24 | 3.7% | 78.7% | ||
| Q3 24 | 15.8% | 53.4% | ||
| Q2 24 | 7.7% | 29.8% | ||
| Q1 24 | 3.1% | — |
营业利润率BRLSPLX
| Q4 25 | — | -51.1% | ||
| Q3 25 | -27.1% | 11.9% | ||
| Q2 25 | -46.7% | 7.5% | ||
| Q1 25 | -42.6% | -41.0% | ||
| Q4 24 | -68.4% | 39.6% | ||
| Q3 24 | -44.8% | 22.2% | ||
| Q2 24 | -94.8% | -18.0% | ||
| Q1 24 | -88.3% | — |
净利率BRLSPLX
| Q4 25 | — | -60.3% | ||
| Q3 25 | -53.2% | 13.2% | ||
| Q2 25 | -64.0% | 1.0% | ||
| Q1 25 | -61.2% | -35.8% | ||
| Q4 24 | -85.3% | 35.6% | ||
| Q3 24 | -59.8% | 18.0% | ||
| Q2 24 | -115.0% | -16.4% | ||
| Q1 24 | -106.8% | — |
每股收益（稀释后）BRLSPLX
| Q4 25 | — | $-0.06 | ||
| Q3 25 | $-0.18 | $0.03 | ||
| Q2 25 | $0.21 | $0.00 | ||
| Q1 25 | $-0.20 | $-0.05 | ||
| Q4 24 | $-0.82 | $0.10 | ||
| Q3 24 | $-0.23 | $0.03 | ||
| Q2 24 | $0.29 | $-0.03 | ||
| Q1 24 | $-0.49 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $14.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-12.9M | $48.2M |
| 总资产 | $56.3M | $82.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BRLSPLX
| Q4 25 | — | $14.7M | ||
| Q3 25 | — | $13.6M | ||
| Q2 25 | — | $17.9M | ||
| Q1 25 | — | $19.5M | ||
| Q4 24 | — | $19.8M | ||
| Q3 24 | — | $27.4M | ||
| Q2 24 | — | $23.4M | ||
| Q1 24 | — | — |
股东权益BRLSPLX
| Q4 25 | — | $48.2M | ||
| Q3 25 | $-12.9M | $52.9M | ||
| Q2 25 | $-9.2M | $49.9M | ||
| Q1 25 | $-4.8M | $45.2M | ||
| Q4 24 | $-695.9K | $43.2M | ||
| Q3 24 | $5.1M | $32.4M | ||
| Q2 24 | $9.9M | $28.6M | ||
| Q1 24 | $16.2M | — |
总资产BRLSPLX
| Q4 25 | — | $82.3M | ||
| Q3 25 | $56.3M | $82.3M | ||
| Q2 25 | $57.3M | $78.5M | ||
| Q1 25 | $58.4M | $73.9M | ||
| Q4 24 | $60.0M | $73.4M | ||
| Q3 24 | $61.9M | $61.6M | ||
| Q2 24 | $63.6M | $91.5M | ||
| Q1 24 | $70.3M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-190.6K | $2.0M |
| 自由现金流经营现金流 - 资本支出 | — | $1.6M |
| 自由现金流率自由现金流/营收 | — | 17.8% |
| 资本支出强度资本支出/营收 | — | 4.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-13.6M |
8季度趋势，按日历期对齐
经营现金流BRLSPLX
| Q4 25 | — | $2.0M | ||
| Q3 25 | $-190.6K | $-3.7M | ||
| Q2 25 | $-2.2M | $-5.2M | ||
| Q1 25 | $-1.4M | $-5.1M | ||
| Q4 24 | $-819.4K | $4.0M | ||
| Q3 24 | $-3.3M | $4.1M | ||
| Q2 24 | $-4.2M | $-3.6M | ||
| Q1 24 | $-6.8M | — |
自由现金流BRLSPLX
| Q4 25 | — | $1.6M | ||
| Q3 25 | — | $-4.2M | ||
| Q2 25 | — | $-5.7M | ||
| Q1 25 | $-1.4M | $-5.4M | ||
| Q4 24 | $-951.6K | $3.6M | ||
| Q3 24 | $-3.7M | $4.0M | ||
| Q2 24 | $-4.7M | $-3.8M | ||
| Q1 24 | $-7.3M | — |
自由现金流率BRLSPLX
| Q4 25 | — | 17.8% | ||
| Q3 25 | — | -23.7% | ||
| Q2 25 | — | -36.2% | ||
| Q1 25 | -20.3% | -53.0% | ||
| Q4 24 | -14.1% | 19.6% | ||
| Q3 24 | -46.1% | 22.4% | ||
| Q2 24 | -86.7% | -28.1% | ||
| Q1 24 | -92.7% | — |
资本支出强度BRLSPLX
| Q4 25 | — | 4.4% | ||
| Q3 25 | — | 2.8% | ||
| Q2 25 | — | 2.8% | ||
| Q1 25 | 0.2% | 3.0% | ||
| Q4 24 | 2.0% | 2.3% | ||
| Q3 24 | 5.6% | 0.5% | ||
| Q2 24 | 9.4% | 1.3% | ||
| Q1 24 | 7.0% | — |
现金转化率BRLSPLX
| Q4 25 | — | — | ||
| Q3 25 | — | -1.58× | ||
| Q2 25 | — | -31.91× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BRLS
暂无分部数据
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
